Brie Carter

IDT Australia (ASX:IDT) reported a narrowing of its losses for the half-year ended Dec. 31, 2025.

Mayne Pharma Group (ASX:MYX) has escalated its legal dispute with Cosette Pharmaceuticals, filing a substantial damages claim in the Supreme Court of New South Wales.

Magellan Financial (ASX:MFG) logged a robust operating profit after tax of $83.1 million for the first half of FY26.

OPENLANE (NYSE:OPLN) reported fourth-quarter revenue that exceeded Wall Street expectations, though higher costs and a difficult Canadian market led to an earnings miss for the digital vehicle marketplace operator.

OneSpaWorld Holdings (NASDAQ:OSW) reported record fourth-quarter revenue that fell just short of Wall Street expectations, as one-time restructuring costs and asset impairments weighed on the cruise-based wellness provider’s bottom line.

The Vita Coco Company (NASDAQ:COCO), a leading brand in the better-for-you beverage category, delivered strong full-year 2025 results driven by robust demand for its flagship Vita Coco Coconut Water portfolio.

Dana (NYSE:DAN) today reported $7.5 billion in sales for the 2025 fiscal year, underscoring a period of significant structural transformation and aggressive capital returns for the global drivetrain and e-propulsion supplier.

Constellium (NYSE:CSTM) posted fourth-quarter 2025 revenue of $2.2 billion on shipments of 365,000 metric tons, with net income attributable to the company reaching $113 million.

Hormel Foods (NYSE:HRL) surprised investors with a preliminary first-quarter profit outlook that cleared analyst hurdles, even as the "Dividend King" moves to shed the most volatile slice of its protein business.

ICL Group (NYSE:ICL), a leading global specialty minerals company, delivered higher fourth-quarter sales and adjusted profitability for 2025, driven by resilient demand in its core specialty crop nutrition and food solutions businesses.